Mirena Efficiency and Tolerability During the First Year of Use

A Multicentre, Open Label, Uncontrolled Study of the Tolerance, Acceptability and Contraceptive Efficacy of Mirena 52 mg®, an Intra-uterine Levonorgestrel Device, During the First Year After Insertion Post-partum

In this trial the efficacy and safety of Mirena was investigated during the first year of use

Inclusion Criteria:

• Women aged 25 to 39 years who sought effective contraception during the post-partum period (i.e. insertion of the device between 6 and 12 weeks after parturition).

Exclusion Criteria:

• Standard exclusion criteria for use of intrauterine hormone devices